AU Stock MarketDetailed Quotes
ATXO Amplia Therapeutics Ltd
- 0.011
- 0.0000.00%
20min DelayMarket Closed Dec 22 16:00 AET
3.02MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.011Pre Close0.00Turnover0.01152wk High0.00%Turnover Ratio274.80MShares0.01152wk Low--EPS TTM1.69MFloat Cap0.050Historical High0.00P/E (Static)153.24MShs Float0.011Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Amplia Therapeutics Ltd Company
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Company Profile
SymbolATXO
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Websitehttps://www.ampliatx.com
Share Registry--
Company Executives
- Name
- Position
- Salary
- Christopher John Burns
- Non Executive Director,Chief Executive Officer,Managing Director
- --
- Warwick Bonner Tong
- Non-Executive Director,Non-Executive Chairman
- --
- Robert Peach
- Non-Executive Director
- --
- Jane Catherine Bell
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data